Administrative Core
行政核心
基本信息
- 批准号:10242888
- 负责人:
- 金额:$ 9.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS related cancerAcquired Immunodeficiency SyndromeAdultAdvocateAfricaAmericanBiological MarkersCervicalClinicalCollaborationsCommunicable DiseasesCommunicationCommunitiesCountryCoupledDecision MakingDevelopment PlansDiagnosticEducational CurriculumEmergency SituationEnvironmentEpigenetic ProcessFoundationsFundingGenomicsGoalsGovernmentGrantHIVHealthHealth PolicyHealth PromotionHealth educationHealthcareHepatitis BHepatitis C virusHuman PapillomavirusIncomeInfrastructureInstitutesInstitutionInternationalInternational AIDSLeadLeadershipLogisticsMalignant NeoplasmsMalignant neoplasm of cervix uteriMedicalMedical EducationMedical ResearchModernizationMolecular EpidemiologyMonitorNational Cancer InstituteNigeriaNigerianOutcomes ResearchPathologyPilot ProjectsPolicy MakerPositioning AttributePreventionPrevention ResearchPrimary carcinoma of the liver cellsProceduresProcessProgress ReportsPublic HealthQuality ControlRecording of previous eventsResearchResearch PersonnelResearch Project GrantsResearch TrainingResourcesScientistServicesSpecialistStructureTimeLineTraining ActivityTraining ProgramsTraining SupportU-Series Cooperative AgreementsUnited States National Institutes of HealthUniversitiesViral hepatitisVirus Diseasesanticancer researchbiomedical informaticscancer carecareercommunity organizationsconflict resolutiondisorder preventionepidemiology studyepigenomicsglobal healthimprovedinfrastructure developmentinterdisciplinary approachinterestinternational centermedical schoolsmeetingsoperationprogramsresponsestatisticsvirus related cancer
项目摘要
Project Summary
We propose to establish a Consortium to study “Epigenomic Biomarkers of HIV-Associated Cancers in Nigeria.”
Our research focus and core services development plan has been prioritized by our Nigerian partners at
University of Jos (UniJos), Plateau State, Nigeria located in the center of the country and University of Lagos
(UniLag), Lagos State in the densely populated southwest. Our focus on the epigenetics of HIV-associated
hepatocellular carcinoma (HCC) and cervical cancer is justified by our extensive collaborative research history
in viral diseases including HIV, human papilloma virus, hepatitis B and C viruses. Northwestern University and
Mayo Medical School will serve as the high-income American partner institutions which is justified by the long
history of research and research training collaboration with the Nigerian institutions coupled with its expertise in
global health and ample complementary resources. The specific aims of the Administrative Core (AC) are: 1.
establish the administration structure, communication mechanisms, decision making and conflict resolution
processes for the U54 Consortium, 2. define the process for establishing and convening the External Advisory
Group (EAG) which will include policy makers, health education specialists, institutional and government leaders,
key opinion leaders and community advocates from Nigeria, and 3. coordinate administrative efforts between
the Biomedical Informatics and Statistics Core (BISC), Career Enhancement Core (CEC), Pathology and
Genomics Core (PGC) and Projects 1 (HCC) and 2 (cervical). The AC will be responsible for the overall
administration, coordination and management of the Consortium as well as facilitation and coordination of
meetings and activities of all cores and projects. The AC will be responsible for evaluating all Consortium
activities, including monitoring project progress, monitoring proposed timelines, overseeing quality control
procedures, and tracking and reporting progress towards stated research goals. We will develop short, medium
and long term metrics for evaluating the quality, quantity, and continuity of the Consortium. An EAG will be
formed and its membership will include: policy makers, health education specialists, institutional and government
leaders, key opinion leaders and community advocates. The overall goal of the AC will be to support and
facilitate research proposed in Projects 1 (HCC) and 2 (cervical), provide administrative logistics for training
activities under the CEC, and manage research services provided by the BISC and PGC.
项目摘要
我们建议建立一个联盟,以研究“尼日利亚与HIV相关癌症的表观基因组生物标志物”。
我们的研究重点和核心服务开发计划已由我们的尼日利亚合作伙伴ATT优先考虑
尼日利亚高原州乔斯大学(UNIJOS),位于柜台和拉各斯大学
(Unilag),西南受欢迎的拉各斯州。
我们广泛的合作研究历史证明了肝细胞癌(HCC)和宫颈癌是合理的
在病毒疾病中,包括HIV,人乳头瘤病毒,乙型肝炎和C病毒。
Mayo医学院担任高收入美国合作伙伴研究所
研究与研究培训的历史与尼日利亚研究所耦合辅助Couths专业知识合作
全球健康和充足的互补资源。
建立管理结构,沟通机制,决策和冲突解决
U54财团的流程,2。定义建立和召开咨询的过程
小组(EAG)将包括政策制定者,健康教育专家,机构和政府领导人,
尼日利亚的关键选择领导者和社区倡导者,以及3。
生物医学信息学和统计核心(BISC),职业增强核心(CEC),病理学和
基因组核心(PGC)和项目1(HCC)和2(宫颈)将对整体响应
财团的管理,协调和管理以及促进和协调
所有核心和项目的会议和活动将重新统治所有财团
活动,包括监视项目进度,监视支撑时间表,监督质量控制
程序,跟踪和报告朝着既定的研究目标的进展。
以及评估财团的质量,数量和纪念品的长期指标。
成立及其成员将包括:政策制定者,健康教育专家,研究所和政府
领导者,主要意见领导者和社区倡导者的总体目标是支持和
促进项目1(HCC)和2(宫颈)提出的研究,为培训提供行政后勤
CEC下的活动以及管理BISC和PGC提供的研究服务。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lifang Hou其他文献
Lifang Hou的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lifang Hou', 18)}}的其他基金
Epigenetic study of oral HPV infection-associated oral cancer in people living with HIV in Nigeria
尼日利亚 HIV 感染者口腔 HPV 感染相关口腔癌的表观遗传学研究
- 批准号:
10530153 - 财政年份:2022
- 资助金额:
$ 9.67万 - 项目类别:
Epigenomic landscape of individual- and neighborhood-level social disadvantages and cardiovascular health disparity
个人和社区层面的社会劣势和心血管健康差异的表观基因组景观
- 批准号:
10701077 - 财政年份:2022
- 资助金额:
$ 9.67万 - 项目类别:
Epigenomic landscape of individual- and neighborhood-level social disadvantages and cardiovascular health disparity
个人和社区层面的社会劣势和心血管健康差异的表观基因组景观
- 批准号:
10531486 - 财政年份:2022
- 资助金额:
$ 9.67万 - 项目类别:
Epigenetic biomarkers of Cervical HPV in women with oral and oropharyngeal HPV, precancer and cancer
患有口腔和口咽 HPV、癌前病变和癌症的女性中宫颈 HPV 的表观遗传生物标志物
- 批准号:
10841283 - 财政年份:2022
- 资助金额:
$ 9.67万 - 项目类别:
Epigenetic study of oral HPV infection-associated oral cancer in people living with HIV in Nigeria
尼日利亚 HIV 感染者口腔 HPV 感染相关口腔癌的表观遗传学研究
- 批准号:
10705727 - 财政年份:2022
- 资助金额:
$ 9.67万 - 项目类别:
Infection-Associated Cancer Research Training Program in Mali
马里感染相关癌症研究培训计划
- 批准号:
10440364 - 财政年份:2021
- 资助金额:
$ 9.67万 - 项目类别:
Infection-Associated Cancer Research Training Program in Mali
马里感染相关癌症研究培训计划
- 批准号:
10645169 - 财政年份:2021
- 资助金额:
$ 9.67万 - 项目类别:
Infection-Associated Cancer Research Training Program in Mali
马里感染相关癌症研究培训计划
- 批准号:
10223788 - 财政年份:2021
- 资助金额:
$ 9.67万 - 项目类别:
High Dimensional Mediation Analysis for DNA Methylation Markers Mediating Cardiovascular Health Metrics and Cardiovascular Diseases
DNA 甲基化标记介导心血管健康指标和心血管疾病的高维中介分析
- 批准号:
9918838 - 财政年份:2019
- 资助金额:
$ 9.67万 - 项目类别:
Epigenomic Biomarkers of HIV-Associated Cancers in Nigeria
尼日利亚艾滋病毒相关癌症的表观基因组生物标志物
- 批准号:
10242887 - 财政年份:2017
- 资助金额:
$ 9.67万 - 项目类别:
相似国自然基金
从CD4+、CD8+T细胞免疫活化分子及其上游调控因子表达探究健脾祛湿法治疗艾滋病免疫调节机制
- 批准号:81460716
- 批准年份:2014
- 资助金额:48.0 万元
- 项目类别:地区科学基金项目
HAART过程中HCV复制增强与肝细胞MAVS抗病毒通路的关系研究
- 批准号:81201286
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
AIDS Malignancies Training and Research International Program (AMTRIP)
艾滋病恶性肿瘤培训和研究国际计划 (AMTRIP)
- 批准号:
10618999 - 财政年份:2022
- 资助金额:
$ 9.67万 - 项目类别:
AIDS Malignancies Training and Research International Program (AMTRIP)
艾滋病恶性肿瘤培训和研究国际计划 (AMTRIP)
- 批准号:
10405562 - 财政年份:2022
- 资助金额:
$ 9.67万 - 项目类别:
Addressing the burden of untreated HIV in cancer patients in sub-Saharan Africa: feasibility and planning for a pragmatic clinical trial
解决撒哈拉以南非洲癌症患者未经治疗的艾滋病毒负担:实用临床试验的可行性和规划
- 批准号:
10252626 - 财政年份:2021
- 资助金额:
$ 9.67万 - 项目类别:
TB Meningitis: Evaluating CSF Immunology to Discover Hidden Disease and Potential Immunomodulatory Therapies
结核性脑膜炎:评估脑脊液免疫学以发现隐藏疾病和潜在的免疫调节疗法
- 批准号:
10335501 - 财政年份:2021
- 资助金额:
$ 9.67万 - 项目类别: